养殖海鲜生产系统市场机会、成长驱动因素、产业趋势分析及预测（2025-2034年）

2024 年全球养殖海鲜生产系统市场价值为 13 亿美元，预计到 2034 年将以 7.6% 的复合年增长率增长至 28 亿美元。

对细胞农业的投资不断增长以及循环水产养殖系统（RAS）的快速发展是推动这一增长的主要因素。该产业正经历着商业化规模生产的明显转型，对先进生物反应器系统和智慧监控技术的需求正在加速成长。美国食品药物管理局（FDA）和美国农业部（USDA）的支持性监管框架，以及生物技术和永续蛋白质生产品质标准的建立，为市场扩张奠定了坚实的基础。养殖海鲜系统透过整合自动化、智慧感测器和精准控制技术，优化生产效率，正在革新现代水产养殖。随着永续蛋白质替代品在全球范围内获得认可，这些系统正被视为满足未来食品需求并维持环境平衡的可行解决方案。细胞水产养殖的可扩展性和製程优化是这些技术快速商业化的关键。大量的研究经费以及使大规模海鲜养殖成为现实且可持续前景的创新，进一步推动了市场的蓬勃发展。

至2034年，3D生物列印系统市场将以12.9%的复合年增长率成长。这项技术正在革新具有复杂组织结构的海鲜生产方式，有助于开发高价值的高端产品。 3D生物列印技术的日益普及归功于其能够提供独特的产品质地和先进的差异化优势，而这些优势是传统生产流程无法比拟的。

2024年，中试规模系统市场规模达4.375亿美元，占总市占率的35%。这些系统在製程验证、规模化测试和监管准备方面发挥着至关重要的作用。模组化循环水产养殖系统（RAS）和中试生物反应器因其灵活性和成本效益，在全面部署前测试生产效率方面越来越受欢迎。中试规模技术的应用支持细胞农业和现代水产养殖的逐步扩张策略，确保在商业化过程中实现最佳製程性能并降低风险。

2024年北美养殖海鲜生产系统市场规模为4.375亿美元，预计2025年至2034年将以8.7%的复合年增长率成长。北美凭藉其先进的生物技术基础设施和健全的监管环境，在该行业保持主导地位。该地区在养殖海鲜生产中对自动化系统和生物技术创新展现出极高的应用率。美国持续的技术发展和加拿大水产养殖业的进步不断巩固该地区的市场地位。

全球养殖海鲜生产系统市场的主要参与者包括 Solaris Biotech（唐纳森）、Hamilton Company、赛默飞世尔科技、赛多利斯、Eppendorf、Steakholder Foods、CytoNest、Culture Biosciences、Prolific Machines、Molecular Devices、Ark Biotech、E-TechTechs、Civa（丹纳赫特Meats、EdiMembre 和 Hitachi Zosen。领先企业正致力于透过开发可扩展的自动化生物加工系统来扩大产能。他们正积极寻求与研究机构和新创公司进行策略合作，以加速细胞培养和组织工程领域的创新。各公司正大力投资智慧监控技术和数位化自动化，以提高系统效率并降低营运成本。透过先进的设计、精准的控制和整合的物联网功能来实现产品差异化是他们关注的重点领域。

目录

第一章：方法论与范围

第二章：执行概要

第三章：行业洞察

• 产业生态系分析
  • 供应商格局
  • 利润率
  • 每个阶段的价值增加
  • 影响价值链的因素
  • 中断
• 产业影响因素
  • 司机
  • 陷阱与挑战
  • 机会
• 成长潜力分析
• 监管环境
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲
• 波特的分析
• PESTEL 分析
• 价格趋势
  • 按地区
  • 按产品规格
• 未来市场趋势
• 技术与创新格局
  • 当前技术趋势
  • 新兴技术
• 专利格局
• 贸易统计（HS编码）（註：仅提供重点国家的贸易统计资料）
  • 主要进口国
  • 主要出口国
• 永续性和环境方面
  • 永续实践
  • 减少废弃物策略
  • 生产中的能源效率
  • 环保倡议
• 碳足迹考量

第四章：竞争格局

• 介绍
• 公司市占率分析
  • 按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • MEA
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 关键进展
  • 併购
  • 合作伙伴关係与合作
  • 新产品发布
  • 扩张计划

第五章：市场估算与预测：依生产技术划分，2021-2034年

• 主要趋势
• 监控系统
• 生物反应器系统
• 细胞培养系统
• 鹰架系统
• 3D生物列印系统

第六章：市场估算与预测：依营运规模划分，2021-2034年

• 主要趋势
• 实验室规模系统
• 中试规模系统
• 商业规模系统

第七章：市场估算与预测：依自动化程度划分，2021-2034年

• 主要趋势
• 手动作业系统
• 半自动化系统
• 全自动系统
• 整合式交钥匙解决方案

第八章：市场估算与预测：依产品应用划分，2021-2034年

• 主要趋势
• 鱼类生产系统
• 贝类生产系统
• 结构化产品製造
• 非结构化产品加工
• 混合产品製造
• 特色及高端产品

第九章：市场估计与预测：依地区划分，2021-2034年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第十章：公司简介

• Solaris Biotech (Donaldson)
• Hamilton Company
• Thermo Fisher Scientific
• Sartorius
• Eppendorf
• Steakholder Foods
• CytoNest
• Culture Biosciences
• Prolific Machines
• Molecular Devices
• Ark Biotech
• E-Tech Group
• Cytiva (Danaher)
• Merck KGaA/EMD
• Applikon Biotechnology

The Global Cultivated Seafood Production Systems Market was valued at USD 1.3 Billion in 2024 and is estimated to grow at a CAGR of 7.6% to reach USD 2.8 Billion by 2034.

Growing investment in cellular agriculture and rapid advancements in recirculating aquaculture systems (RAS) are major factors driving this growth. The industry is witnessing a clear transition toward commercial-scale production, with demand for advanced bioreactor systems and smart monitoring technologies accelerating. Supportive regulatory frameworks from the FDA and USDA, along with the establishment of quality standards for biotechnology and sustainable protein manufacturing, are providing a strong foundation for market expansion. Cultivated seafood systems are revolutionizing modern aquaculture by integrating automation, smart sensors, and precision control technologies that optimize production efficiency. As sustainable protein alternatives gain global traction, these systems are being positioned as a viable solution for meeting future food demands while maintaining environmental balance. Enhanced scalability and process optimization in cellular aquaculture are key to the rapid commercialization of these technologies. The market's momentum is further fueled by significant funding for research, coupled with innovations that make large-scale seafood cultivation a realistic and sustainable prospect.

The 3D bioprinting systems segment will grow at a CAGR of 12.9% through 2034. This technology is transforming the production of structured seafood with complex tissue composition, enabling the development of high-value, premium products. The growing adoption of 3D bioprinting is attributed to its ability to deliver unique product textures and advanced differentiation compared to conventional production processes.

The pilot-scale systems segment accounted for USD 437.5 million in 2024, representing a 35% share. These systems play an essential role in process validation, scalability testing, and regulatory readiness. Modular RAS and pilot bioreactors are gaining popularity for their flexibility and cost-effectiveness in testing production efficiency before full-scale deployment. The adoption of pilot-scale technologies supports gradual expansion strategies in both cellular agriculture and modern aquaculture, ensuring optimal process performance and risk reduction during commercialization.

North America Cultivated Seafood Production Systems Market was valued at USD 437.5 million in 2024 and is anticipated to grow at a CAGR of 8.7% from 2025 to 2034. North America maintains its dominance in this industry due to its advanced biotechnology infrastructure and strong regulatory environment. The region demonstrates a high rate of adoption for automated systems and biotechnological innovations in cultivated seafood production. Ongoing technological developments in the United States and progressive aquaculture advancements in Canada continue to strengthen the region's market position.

Major players in the Global Cultivated Seafood Production Systems Market include Solaris Biotech (Donaldson), Hamilton Company, Thermo Fisher Scientific, Sartorius, Eppendorf, Steakholder Foods, CytoNest, Culture Biosciences, Prolific Machines, Molecular Devices, Ark Biotech, E-Tech Group, Cytiva (Danaher), Merck KGaA/EMD, Applikon Biotechnology, Matrix Meats, EdiMembre, and Hitachi Zosen. Leading companies are focusing on expanding their production capacities through the development of scalable and automated bioprocessing systems. Strategic collaborations with research institutions and startups are being pursued to accelerate innovation in cell culture and tissue engineering. Firms are heavily investing in smart monitoring technologies and digital automation to enhance system efficiency and reduce operational costs. Product differentiation through advanced design, precision control, and integrated IoT capabilities is a major area of focus.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Production technology trends
  • 2.2.2 Scale of operation trends
  • 2.2.3 Automation level trends
  • 2.2.4 Product application trends
  • 2.2.5 Regional trends
• 2.3 TAM Analysis, 2025-2034
• 2.4 CXO perspectives: Strategic imperatives
  • 2.4.1 Executive decision points
  • 2.4.2 Critical success factors
• 2.5 Future Outlook and Strategic Recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Profit margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factor affecting the value chain
  • 3.1.5 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Drivers
  • 3.2.2 Pitfalls & Challenges
  • 3.2.3 Opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter's analysis
• 3.6 PESTEL analysis
• 3.7 Price trends
  • 3.7.1 By region
  • 3.7.2 By product format
• 3.8 Future market trends
• 3.9 Technology and Innovation landscape
  • 3.9.1 Current technological trends
  • 3.9.2 Emerging technologies
• 3.10 Patent Landscape
• 3.11 Trade statistics (HS code) ( Note: the trade statistics will be provided for key countries only)
  • 3.11.1 Major importing countries
  • 3.11.2 Major exporting countries
• 3.12 Sustainability and environmental aspects
  • 3.12.1 Sustainable practices
  • 3.12.2 Waste reduction strategies
  • 3.12.3 Energy efficiency in production
  • 3.12.4 Eco-friendly initiatives
• 3.13 Carbon footprint consideration

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 LATAM
    • 4.2.1.5 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New Product Launches
  • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Production Technology, 2021-2034 (USD Million & Units)

• 5.1 Key trends
• 5.2 Monitoring & control systems
• 5.3 Bioreactor systems
• 5.4 Cell culture systems
• 5.5 Scaffolding systems
• 5.6 3d bioprinting systems

Chapter 6 Market Estimates and Forecast, By Scale of Operation, 2021-2034 (USD Million & Units)

• 6.1 Key trends
• 6.2 Laboratory scale systems
• 6.3 Pilot scale systems
• 6.4 Commercial scale systems

Chapter 7 Market Estimates and Forecast, By Automation Level, 2021-2034 (USD Million & Units)

• 7.1 Key trends
• 7.2 Manual operation systems
• 7.3 Semi-automated systems
• 7.4 Fully automated systems
• 7.5 Integrated turnkey solutions

Chapter 8 Market Estimates and Forecast, By Product Application, 2021-2034 (USD Million & Units)

• 8.1 Key trends
• 8.2 Finfish production systems
• 8.3 Shellfish production systems
• 8.4 Structured product manufacturing
• 8.5 Unstructured product processing
• 8.6 Hybrid product manufacturing
• 8.7 Specialty & premium products

Chapter 9 Market Estimates and Forecast, By Region, 2021-2034 (USD Million & Units)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Solaris Biotech (Donaldson)
• 10.2 Hamilton Company
• 10.3 Thermo Fisher Scientific
• 10.4 Sartorius
• 10.5 Eppendorf
• 10.6 Steakholder Foods
• 10.7 CytoNest
• 10.8 Culture Biosciences
• 10.9 Prolific Machines
• 10.10 Molecular Devices
• 10.11 Ark Biotech
• 10.12 E-Tech Group
• 10.13 Cytiva (Danaher)
• 10.14 Merck KGaA/EMD
• 10.15 Applikon Biotechnology